Cantor Fitzgerald’s Axonics, Inc. Common Stock AXNX Stock Holding History

Cantor Fitzgerald’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21,999	Closed	-$1.53M	–	363
2024 Q3	$1.53M	Buy	21,999 +17,999	+450%	+$1.23M	0.04%	63
2024 Q2	$269K	Sell	4,000 -12,000	-75%	-$808K	0.05%	135
2024 Q1	$1.1M	Buy	+16,000	New	+$1.08M	0.26%	54

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cantor Fitzgerald's AXNX Position: Q4 2024 in Review

Cantor Fitzgerald sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 21,999 shares — an estimated $1.53M sold.

Cantor Fitzgerald first reported a position in AXNX in Q1 2024 and held it in 3 quarters. The position peaked at $1.53M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Cantor Fitzgerald reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Cantor Fitzgerald sold 21,999 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $1.53M.
Cantor Fitzgerald first reported a position in Axonics, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
Cantor Fitzgerald's Axonics, Inc. Common Stock position peaked at $1.53M in Q3 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Cantor Fitzgerald's 13F filing for Q4 2024, filed 14 Feb 2025.